Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalTimes Interest Earned

MoonLake Immunotherapeutics (MLTX) Interest Coverage Ratio (2022 - 2026)

MoonLake Immunotherapeutics' Interest Coverage Ratio history spans 3 years, with the latest figure at 30.86 for Q1 2026.

  • Quarterly Interest Coverage Ratio rose 98.83% to 30.86 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 28.15 through Mar 2026, up 99.7% year-over-year, with the annual reading at 33.78 for FY2025, N/A changed from the prior year.
  • Interest Coverage Ratio came in at 30.86 for Q1 2026, up from 32.71 in the prior quarter.
  • In the past five years, Interest Coverage Ratio ranged from a high of 22.34 in Q3 2025 to a low of 24265.32 in Q1 2022.
  • The 3-year median for Interest Coverage Ratio is 31.78 (2025), against an average of 4503.18.
  • The largest YoY upside for Interest Coverage Ratio was 98.83% in 2026 against a maximum downside of 98.83% in 2026.
  • MoonLake Immunotherapeutics' Interest Coverage Ratio stood at 24265.32 in 2022, then skyrocketed by 99.87% to 32.71 in 2025, then grew by 5.64% to 30.86 in 2026.
  • Per Business Quant, the three most recent readings for MLTX's Interest Coverage Ratio are 30.86 (Q1 2026), 32.71 (Q4 2025), and 22.34 (Q3 2025).